209 related articles for article (PubMed ID: 31884596)
1. Advancing Gene Therapy for PDE6A Retinitis Pigmentosa.
Petersen-Jones SM; Occelli LM; Biel M; Michalakis S
Adv Exp Med Biol; 2019; 1185():103-107. PubMed ID: 31884596
[TBL] [Abstract][Full Text] [Related]
2. Gene Supplementation Rescues Rod Function and Preserves Photoreceptor and Retinal Morphology in Dogs, Leading the Way Toward Treating Human
Occelli LM; Schön C; Seeliger MW; Biel M; Michalakis S; Petersen-Jones SM
Hum Gene Ther; 2017 Dec; 28(12):1189-1201. PubMed ID: 29212382
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a canine model of autosomal recessive retinitis pigmentosa due to a PDE6A mutation.
Tuntivanich N; Pittler SJ; Fischer AJ; Omar G; Kiupel M; Weber A; Yao S; Steibel JP; Khan NW; Petersen-Jones SM
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):801-13. PubMed ID: 18775863
[TBL] [Abstract][Full Text] [Related]
4. Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosa.
Pang JJ; Dai X; Boye SE; Barone I; Boye SL; Mao S; Everhart D; Dinculescu A; Liu L; Umino Y; Lei B; Chang B; Barlow R; Strettoi E; Hauswirth WW
Mol Ther; 2011 Feb; 19(2):234-42. PubMed ID: 21139570
[TBL] [Abstract][Full Text] [Related]
5. Retinitis pigmentosa: impact of different Pde6a point mutations on the disease phenotype.
Sothilingam V; Garcia Garrido M; Jiao K; Buena-Atienza E; Sahaboglu A; Trifunović D; Balendran S; Koepfli T; Mühlfriedel R; Schön C; Biel M; Heckmann A; Beck SC; Michalakis S; Wissinger B; Seeliger MW; Paquet-Durand F
Hum Mol Genet; 2015 Oct; 24(19):5486-99. PubMed ID: 26188004
[TBL] [Abstract][Full Text] [Related]
6. Restoration of vision in the pde6β-deficient dog, a large animal model of rod-cone dystrophy.
Petit L; Lhériteau E; Weber M; Le Meur G; Deschamps JY; Provost N; Mendes-Madeira A; Libeau L; Guihal C; Colle MA; Moullier P; Rolling F
Mol Ther; 2012 Nov; 20(11):2019-30. PubMed ID: 22828504
[TBL] [Abstract][Full Text] [Related]
7. Gene Therapy in a Large Animal Model of PDE6A-Retinitis Pigmentosa.
Mowat FM; Occelli LM; Bartoe JT; Gervais KJ; Bruewer AR; Querubin J; Dinculescu A; Boye SL; Hauswirth WW; Petersen-Jones SM
Front Neurosci; 2017; 11():342. PubMed ID: 28676737
[TBL] [Abstract][Full Text] [Related]
8. Splice-site mutations identified in PDE6A responsible for retinitis pigmentosa in consanguineous Pakistani families.
Khan SY; Ali S; Naeem MA; Khan SN; Husnain T; Butt NH; Qazi ZA; Akram J; Riazuddin S; Ayyagari R; Hejtmancik JF; Riazuddin SA
Mol Vis; 2015; 21():871-82. PubMed ID: 26321862
[TBL] [Abstract][Full Text] [Related]
9. ERG assessment of altered retinal function in canine models of retinitis pigmentosa and monitoring of response to translatable gene augmentation therapy.
Pasmanter N; Occelli LM; Petersen-Jones SM
Doc Ophthalmol; 2021 Oct; 143(2):171-184. PubMed ID: 33818677
[TBL] [Abstract][Full Text] [Related]
10. Mid-stage intervention achieves similar efficacy as conventional early-stage treatment using gene therapy in a pre-clinical model of retinitis pigmentosa.
Wert KJ; Sancho-Pelluz J; Tsang SH
Hum Mol Genet; 2014 Jan; 23(2):514-23. PubMed ID: 24101599
[TBL] [Abstract][Full Text] [Related]
11. Increased Plasma cGMP in a Family With Autosomal Recessive Retinitis Pigmentosa Due to Homozygous Mutations in the PDE6A Gene.
Kjellström U; Veiga-Crespo P; Andréasson S; Ekström P
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6048-6057. PubMed ID: 27820873
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.
Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Becirovic E; Koch F; Seide C; Beck SC; Seeliger MW; Biel M; Mühlfriedel R; Michalakis S
Hum Mol Genet; 2012 Oct; 21(20):4486-96. PubMed ID: 22802073
[TBL] [Abstract][Full Text] [Related]
13. AAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa.
Xue Y; Wang SK; Rana P; West ER; Hong CM; Feng H; Wu DM; Cepko CL
Elife; 2021 Apr; 10():. PubMed ID: 33847261
[TBL] [Abstract][Full Text] [Related]
14. AAV-mediated gene therapy for retinal degeneration in the rd10 mouse containing a recessive PDEbeta mutation.
Pang JJ; Boye SL; Kumar A; Dinculescu A; Deng W; Li J; Li Q; Rani A; Foster TC; Chang B; Hawes NL; Boatright JH; Hauswirth WW
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4278-83. PubMed ID: 18586879
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Clinical Follow-up and Genetic Spectrum of Patients With Rod-Cone Dystrophy Associated With Mutations in PDE6A and PDE6B.
Khateb S; Nassisi M; Bujakowska KM; Méjécase C; Condroyer C; Antonio A; Foussard M; Démontant V; Mohand-Saïd S; Sahel JA; Zeitz C; Audo I
JAMA Ophthalmol; 2019 Jun; 137(6):669-679. PubMed ID: 30998820
[TBL] [Abstract][Full Text] [Related]
16. Development of a translatable gene augmentation therapy for CNGB1-retinitis pigmentosa.
Occelli LM; Zobel L; Stoddard J; Wagner J; Pasmanter N; Querubin J; Renner LM; Reynaga R; Winkler PA; Sun K; Marinho LFLP; O'Riordan CR; Frederick A; Lauer A; Tsang SH; Hauswirth WW; McGill TJ; Neuringer M; Michalakis S; Petersen-Jones SM
Mol Ther; 2023 Jul; 31(7):2028-2041. PubMed ID: 37056049
[TBL] [Abstract][Full Text] [Related]
17. Successful gene therapy in the RPGRIP1-deficient dog: a large model of cone-rod dystrophy.
Lhériteau E; Petit L; Weber M; Le Meur G; Deschamps JY; Libeau L; Mendes-Madeira A; Guihal C; François A; Guyon R; Provost N; Lemoine F; Papal S; El-Amraoui A; Colle MA; Moullier P; Rolling F
Mol Ther; 2014 Feb; 22(2):265-277. PubMed ID: 24091916
[TBL] [Abstract][Full Text] [Related]
18. Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized
Dufour VL; Cideciyan AV; Ye GJ; Song C; Timmers A; Habecker PL; Pan W; Weinstein NM; Swider M; Durham AC; Ying GS; Robinson PM; Jacobson SG; Knop DR; Chulay JD; Shearman MS; Aguirre GD; Beltran WA
Hum Gene Ther; 2020 Feb; 31(3-4):253-267. PubMed ID: 31910043
[TBL] [Abstract][Full Text] [Related]
19. Gene Therapy Successfully Delays Degeneration in a Mouse Model of
Schön C; Sothilingam V; Mühlfriedel R; Garcia Garrido M; Beck SC; Tanimoto N; Wissinger B; Paquet-Durand F; Biel M; Michalakis S; Seeliger MW
Hum Gene Ther; 2017 Dec; 28(12):1180-1188. PubMed ID: 29212391
[TBL] [Abstract][Full Text] [Related]
20. Dose Range Finding Studies with Two
Song C; Dufour VL; Cideciyan AV; Ye GJ; Swider M; Newmark JA; Timmers AM; Robinson PM; Knop DR; Chulay JD; Jacobson SG; Aguirre GD; Beltran WA; Shearman MS
Hum Gene Ther; 2020 Jul; 31(13-14):743-755. PubMed ID: 32414297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
